Evidence map›Paper›PMID 39362995›Full record

ArticleEuropean journal of human genetics : EJHG2025

Equity and timeliness as factors in the effectiveness of an ethical prenatal sequencing service: reflections from parents and professionals.

Michelle Peter, Melissa Hill, Jane Fisher, Morgan Daniel, Hannah McInnes-Dean, Rhiannon Mellis, Holly Walton, Caroline Lafarge, Kerry Leeson-Beevers, Sophie Peet and 4 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2026
    Article
  3. Article
  4. Spring in EJHG.European journal of human genetics : EJHG · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Michelle PeterNorth Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK. michelle.lowe@ucl.ac.uk.ORCID 0000-0002-4977-8708
Melissa HillNorth Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.ORCID 0000-0003-3900-1425
Jane FisherAntenatal Results and Choices, London, UK.
Morgan DanielNorth Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.ORCID 0000-0002-4455-5521
Hannah McInnes-DeanNorth Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.ORCID 0000-0002-5204-0069
Rhiannon MellisNorth Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Holly WaltonBehavioural Science and Health, Institute of Epidemiology and Health Care, University College London, London, UK.
Caroline LafargeSchool of Human and Social Sciences, University of West London, London, UK.
Kerry Leeson-BeeversAlström Syndrome UK, Torquay, UK.
Sophie PeetGenetic Alliance UK, London, UK.
Dagmar TaponQueen Charlotte's & Chelsea Hospital, Imperial College Healthcare NHS Trust, London, UK.ORCID 0000-0003-3837-4764
Sarah L WynnUnique - Rare Chromosome Disorder Support Group, Oxted, UK.ORCID 0000-0001-6531-8181
Lyn S ChittyNorth Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Michael ParkerThe Ethox Centre, Nuffield Department of Population Health and Wellcome Centre for Ethics and Humanities, University of Oxford, Oxford, UK.ORCID 0000-0002-7054-4711

Funding

DH | NIHR | Health Services Research Programme (NIHR Health Services Research Programme) NIHR127829
6 · The paper itself

Abstract

Prenatal sequencing tests are being introduced into clinical practice in many developed countries. In part due to its greater ability to detect genetic variation, offering prenatal sequencing can present ethical challenges. Here we review ethical issues arising following the implementation of prenatal sequencing in the English National Health Service (NHS). We analysed semi structured interviews conducted with 48 parents offered prenatal sequencing and 63 health professionals involved in delivering the service to identify the ethical issues raised. Two main themes were identified: (1) Equity of access (including issues around eligibility criteria, laboratory analytical processes, awareness and education of clinicians, fear of litigation, geography, parental travel costs, and access to private healthcare), and (2) Timeliness and its impact on parental decision-making in pregnancy (in the context of the law around termination of pregnancy, decision-making in the absence of prenatal sequencing results, and the "importance" of prenatal sequencing results). Recognising both the practical and systemic ethical issues that arise out of delivering a national prenatal sequencing service is crucial. Although specific to the English context, many of the issues we identified are applicable to prenatal sequencing services more broadly. Education of health professionals and parents will help to mitigate some of these ethical issues.

Indexed as

Genetic TestingHealth PersonnelParentsPrenatal DiagnosisAdultDecision MakingFemaleHumansMalePregnancy

Identifiers

PMID39362995
PMCPMC11894143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.